Mineralys Therapeutics is based in Philadelphia, PA. It has raised $328M in total funding. Latest round: Series A.
Mineralys Therapeutics is based in Philadelphia, PA. Mineralys Therapeutics has raised $328M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in April 2021. The round record for Mineralys Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include HBM Healthcare Investments, Samsara BioCapital, Catalys Pacific, Adam Street Partners. 4 distinct backers are named across the disclosed rounds.
Every Mineralys Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Philadelphia at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026